Henan Medical University
Also known as: Henan Cancer Hospital | Henan Cancer Hospital，Henan，China | Henan Cancer Hospital/The affiliated Cancer Hospital of Zhengzhou University | Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university | Henan Eye Institue, Henan, China | Henan Eye Institute, Henan, China | HeNanHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university | Henan Mental Hospital | Henan Oncology Hospital | Henan People's hospital | Henan Provincial Hospital | Henan Science and Technology | Henan Tumor Hospital | Henan University of TCM affiliated hospital | LiNing | Study Principal Investigator Henan Cancer Hospital | The Clinical Medical College, The First Affiliated Hospital of Henan Science and Technology | The First Affiliated Hospital of Henan University of Science and Technology | The First Affiliated Hospital of Henan University of Science & Technology | The First Affiliated Hospital of Henan University of Traditional Chinese Medicine | The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine | The second people's hospital of Tianjin | WuHui | Xinxiang Central Hospital | Xinxiang Central Hospital of Henan province | Zhengzhou Yihe Hospital Affiliated to Henan University
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2005Last known activity
Dec 31, 2025
Timeline
1910s
- Jun 1, 1912
Henan Medical University— Founded
Drugs by trial phase (298 distinct, 332 trials)
Phase 4 (57 own, 0 via acquisition)
Phase 3 (63 own, 0 via acquisition)
Phase 2 (108 own, 0 via acquisition)
Phase 1 (35 own, 0 via acquisition)
- autologous natural killer cells
- pembrolizumab
- margetuximab
- personalized neoantigen vaccine
- pegloticase
- Ivarmacitinib
- autologous dendritic cells
- autologous cytokine induced killer cells
- autologous mesenchymal stem cell-derived neural progenitors
- prednisolone
- sodium chloride
- autologous cd19/cd22 chimeric antigen receptor t-cells
- hiv-1 specific car-t cells
- hs-10342
- car19 t cells carrying cytoplasmic activated pd-1
- +20 more
Other trials (35 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma of Lung
- Biliary Tract Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Cerebral Infarction
- Chronic Disease
- Cognitive Dysfunction
- Colorectal Neoplasms
- Communicable Diseases
- Compulsive Personality Disorder
- Disease
- Dwarfism, Pituitary
- Endocrine System Diseases
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Fallopian Tube Neoplasms
- Fibrosis
- Glioma
- Graves Ophthalmopathy
- Heart Failure
- Heart Neoplasms
- Hemophilia A
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hodgkin Disease
- Hypersensitivity
- Hypertension
- Hypothyroidism
- Infections
- Infertility
- Infertility, Female
- Intestinal Neoplasms
- Ischemia
- Leukemia
- Leukemia, B-Cell
- Leukemia, Large Granular Lymphocytic
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Plasma Cell
- Leukemia, T-Cell
- Liver Cirrhosis
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Melanoma
- Menopause, Premature
- Multiple Myeloma
- Nasopharyngeal Carcinoma
- Nausea
- Neoplasms
- Neoplasms, Plasma Cell
- Neuroendocrine Tumors
- Neurotoxicity Syndromes
- Obsessive-Compulsive Disorder
- Osteosarcoma
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Parkinson Disease
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Premature Birth
- Primary Ovarian Insufficiency
- Pulmonary Disease, Chronic Obstructive
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Recurrence
- Renal Artery Obstruction
- Sarcoma
- Schizophrenia
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Stroke
- Thrombocytopenia
- Tic Disorders
- Tics
- Tonsillitis
- Tourette Syndrome
- Triple Negative Breast Neoplasms
- Urinary Bladder Neoplasms
- Uterine Cervical Neoplasms
- Vomiting
- Wounds and Injuries
Recent trials (50)
- NCT07258121OfficialPhase 1/Phase 2Dec 31, 2025
- NCT07246070CollaboratorPhase 2Dec 31, 2025
- NCT07254416CollaboratorPhase 4Dec 15, 2025
- NCT07281846CollaboratorN/ANov 15, 2025
- NCT07198672Lead sponsorN/AOct 31, 2025
- NCT07198672Sponsor investigatorN/AOct 31, 2025
- NCT07206745OfficialN/AOct 1, 2025
- NCT07206745CollaboratorN/AOct 1, 2025
- NCT07125950Lead sponsorPhase 2Sep 30, 2025
- NCT07125950OfficialPhase 2Sep 30, 2025
- NCT07125950Sponsor investigatorPhase 2Sep 30, 2025
- NCT07243379CollaboratorPhase 4Sep 25, 2025
- NCT07136974Sponsor investigatorPhase 2Sep 1, 2025
- NCT07136974Lead sponsorPhase 2Sep 1, 2025
- NCT07153744CollaboratorPhase 4Sep 1, 2025
Details
- Founded
- CN Jun 1, 1912
- Last known activity
- Dec 31, 2025